Is Fibrous Dysplasia hereditary?

Fibrous dysplasia is a genetic condition, but it is not hereditary, meaning it is not passed down from parents to their children. It is caused by a sporadic, post-zygotic somatic mutation in the GNAS gene that occurs after conception, meaning the mutation is present only in the affected tissues rather than in the individual's germline (egg or sperm cells).

Is Fibrous Dysplasia a hereditary condition?

While fibrous dysplasia is a genetic condition, it is strictly non-hereditary. In medical genetics, we distinguish between "genetic" (caused by an alteration in DNA) and "hereditary" (passed from parent to offspring). Because the mutation in fibrous dysplasia occurs randomly during early embryonic development, it is considered a de novo or sporadic event. An affected individual cannot pass the condition to their children because the mutation is not present in their reproductive cells.

What causes Fibrous Dysplasia?

The underlying cause of fibrous dysplasia is a somatic mutation in the GNAS gene, specifically located on chromosome 20q13. This mutation leads to the overproduction of cyclic AMP, which causes bone-forming cells to malfunction. Instead of creating healthy, mature bone, these cells produce abnormal, fibrous, or "woven" bone tissue. Because this mutation occurs after the egg is fertilized, the severity and location of the disease depend on which cells were affected during the individual's development.

How does the genetic nature of Fibrous Dysplasia affect family planning?

Because fibrous dysplasia is not an inherited disease, there is no increased risk for siblings or offspring of an affected person to develop the condition compared to the general population. Genetic counseling is often sought by families to alleviate anxiety regarding inheritance. In our experience at DiseaseMaps.org, where 280 people with fibrous dysplasia have shared their journeys, we understand how vital it is to have clear, evidence-based reassurance that this condition will not be passed to future generations.

Is genetic testing recommended for Fibrous Dysplasia?

Genetic testing for fibrous dysplasia is generally not required for clinical diagnosis, as the condition is typically identified through characteristic findings on imaging (such as X-rays, CT scans, or MRIs) and clinical examination. However, genetic testing may be utilized in specific clinical scenarios:

• To confirm the diagnosis in atypical or complex cases where imaging is inconclusive.


• To differentiate fibrous dysplasia from other bone lesions or genetic syndromes.


• To assist in identifying McCune-Albright syndrome, a related condition where the same GNAS mutation causes bone lesions along with endocrine abnormalities and skin pigmentation.


• To provide peace of mind for families concerned about the recurrence risk in future pregnancies.

Next steps

• Consult with a genetic counselor or a clinical geneticist if you have concerns about the diagnosis or family planning.


• Coordinate care with an orthopedic specialist or an endocrinologist experienced in managing bone health.


• Connect with the 280 members on DiseaseMaps.org to share experiences and find emotional support within the rare disease community.


• Maintain regular monitoring with imaging as recommended by your physician to track any changes in affected bone areas.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fibrous Dysplasia.


• Orphanet: Fibrous Dysplasia of Bone.


• OMIM (Online Mendelian Inheritance in Man): Fibrous Dysplasia of Bone (#174800).


• Fibrous Dysplasia Foundation: Information on genetics and clinical management.